MedTrace Logo

Longitudinal Optic Neuritis Study (LONS)

NCT00000147 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2006-05-29

No results posted yet for this study

Summary

To assess the beneficial and adverse effects of corticosteroid treatment for optic neuritis.

To determine the natural history of vision in patients who suffer optic neuritis.

To identify risk factors for the development of multiple sclerosis in patients with optic neuritis.

Conditions

Interventions

DRUG

Methylprednisolone

DRUG

Prednisone

Sponsors & Collaborators

  • National Eye Institute (NEI)

    lead NIH

Study Design

Purpose
TREATMENT
Masking
SINGLE

Eligibility

Min Age
18 Years
Max Age
46 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1988-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00000147 on ClinicalTrials.gov